Page last updated: 2024-08-26
deoxypyridinoline and Glomerulonephritis, Minimal Change
deoxypyridinoline has been researched along with Glomerulonephritis, Minimal Change in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Arisaka, O; Kano, K; Nishikura, K; Yamada, Y | 1 |
Trials
1 trial(s) available for deoxypyridinoline and Glomerulonephritis, Minimal Change
Article | Year |
---|---|
No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria.
Topics: Acid Phosphatase; Adolescent; Adult; Alkaline Phosphatase; Amino Acids; Bone Density; Child; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoenzymes; Male; Nephritis; Nephrosis, Lipoid; Osteocalcin; Prospective Studies; Tartrate-Resistant Acid Phosphatase | 2005 |